Controversies in Modern Eye Care 2023: Living with an untreatable eye disease

Video

Tina Mac Donald, OD, shares highlights from her presentation on living with an untreatable eye disease, which she presented during the 2023 Controversies in Modern Eye Care meeting.

Tina Mac Donald, OD, shares what she hopes attendees took away from her discussion on living with an untreatable eye disease, which she co-presented during the 17th annual Controversies in Modern Eye Care symposium at the Skirball Cultural Center in Los Angeles, California.

This transcript has been edited for clarity.

Tina Mac Donald, OD:

Hi, my name is Tina Mac Donald, I was one of the presenters today at this fabulous conference [and] I work for Western University of Health Sciences College of Optometry.

My presentation today was on living with an untreatable eye disease—specifically macular degeneration. I hope reviewing the prevalence and incidence of this devastating condition was helpful for the attendees, and I hope I gave them takeaways regarding simple things like improved lighting, filters, and some magnification to help those with better acuities. And I hope they learned about amazing technology including AI, VR, and augmented reality to help those return to a more independent state in the lives.

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Extended lotilaner 0.25% therapy shows meibomian gland benefits
Mitch Ibach, OD, FAAO, details a presentation he gave with Tanner Ferguson, MD, at the Collaborative Care Symposium 2025.
Carolyn Majcher, OD, FAAO, details a Collaborative Care Symposium 2025 presentation given with Prethy Rao, MD.
Mitch Ibach, OD, FAAO, details the importance of identifying the best candidates and practicing comanagement for refractive surgery.
Peter Hersh, MD, stated that the key takeaway from a handful of presentations he gave at CCS 2025 is that successfully treating patients with keratoconus is identifying the disease early.
Mitch Ibach, OD, FAAO, details the importance to unveiling the underlying cause of dry eye in a CCS 2025 presentation.
Steven Greenstein, MD, one of the cochairs of the Collaborative Care Symposium gave some insight into the upcoming conference and what attendees can expect.
Dr Julie Poteet reports on patient-reported outcomes using lipid-containing artificial tear
Karl Stonecipher ASCRS 2025
AnnMarie Hipsley, DPT, PhD, at ASCRS 2025
© 2025 MJH Life Sciences

All rights reserved.